Silexion Therapeutics Corp (SLXN)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-K/A | FY-2025 | |||
| — | 8-K (2026-05-18) · 99.1 | |||
| 10-QLatest | Q1-2026 | — | ||
| 10-KLatest | FY-2025 | — | ||
| 10-Q | Q3-2025 | 8-K (2025-11-12) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-12) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-13) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-03-18) · 99.1 | 8-K (2025-01-14) · 99.1 · 99.2 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-14) · 99.1 | ||
| 10-Q | Q2-2024 | — |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | — |
|
| Document and Entity Information | ||
| Statements | ||
| Consolidated Balance Sheets | — |
|
| Unaudited Condensed Consolidated Balance Sheets | — |
|
| Consolidated Balance Sheets (P) | — |
|
| Unaudited Condensed Consolidated Balance Sheets (P) | — |
|
| Consolidated Statements of Operations | — |
|
| Unaudited Condensed Consolidated Statements of Operations | — |
|
| Consolidated Statements of Operations (P) | — |
|
| Unaudited Condensed Consolidated Statements of Operations (P) | — |
|
| Consolidated Statements of Changes In Redeemable Convertible Preferred Shares and Capital Deficiency (deficit) | — |
|
| Consolidated Statements of Changes In Redeemable Convertible Preferred Shares and Shareholders' Equity (capital Deficiency) | — |
|
| Unaudited Condensed Consolidated Statements of Changes In Shareholders' Equity | — |
|
| Unaudited Condensed Consolidated Statements of Stockholders' Equity (deficit) | — |
|
| Unaudited Convertible Preferred Shares and Shareholders' Equity (capital Deficiency) | — |
|
| Consolidated Statements of Cash Flows | — |
|
| Unaudited Condensed Consolidated Statements of Cash Flows | — |
|
| Notes | ||
| At The Market Offering Agreement | — |
|
| Commitments and Contingent Liabilities | — |
|
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Fair Value Measurements | ||
| Financial Instruments Issued and Assumed In Transactions | ||
| General | ||
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Leases | ||
| Net Loss Per Share | ||
| Pay Vs Performance Disclosure | ||
| Promissory Notes | — |
|
| Property and Equipment, Net | — |
|
| Redeemable Convertible Preferred Shares and Shareholders' Equity | ||
| Related Party Promissory Note | — |
|
| Segment Information | ||
| Share-based Compensation | ||
| Shareholders' Equity | ||
| Significant Accounting Policies | ||
| Subsequent Events | ||
| Supplementary Financial Statement Information | ||
| Transactions and Balances With Related Parties | ||
| Underwriters Promissory Note | — |
|
| Warrants To Purchase Ordinary Shares | ||
| Warrants To Purchase Preferred Shares | ||